Bio-Reference (BRLI) in Focus: Stock Tumbles 7.7% - Tale of the Tape
Bio-Reference Laboratories Inc. ( BRLI ) saw a big move last session, as the company's shares fell by nearly 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $33.9 to $36.5 in the past one-month time frame.
On Mar 5, the company announced first quarter of fiscal 2015 earnings per share of 24 cents, which missed the Zacks Consensus Estimate by 12 cents. Also, BRLI's quarterly revenues of $ $208.8 million lagged the Zacks Consensus Estimate of $219.0 million.
This Medical company has seen a flat track record when it comes to current year estimate revisions, as there has been no revision on either side over the past few weeks. The consensus for earnings estimate hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
BRLI currently has a Zacks Rank #3(Hold).
A better-ranked stock in the Medical industry is Halyard Health, Inc. ( HYH ) which holds a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report